(Q53524448)

15 May 2018

title

Report on the quality of life analysis from the phase III trial of pion versus photon radiotherapy in locally advanced prostate cancer. (English)

1 reference

15 May 2018

adaptive radiation therapy

main subject

0 references

phase III clinical trial

0 references

1 reference

Duncan GG

1

1 reference

15 May 2018

Philips N

series ordinal

2

1 reference

15 May 2018

Pickles T

series ordinal

3

1 reference

15 May 2018

publication date

1 April 2000

1 reference

15 May 2018

European Journal of Cancer

published in

1 reference

15 May 2018

volume

36

1 reference

15 May 2018

issue

6

1 reference

15 May 2018

page(s)

759-765

1 reference

15 May 2018

Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: results of a randomized prospective trial

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Neutron radiation and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

The Possibility of Therapeutic Applications of Beams of Negative π-Mesons

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

The response of mouse tumours to fractionated doses of pions: determination of therapeutic gain factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

The response of murine b-16 melanoma to fractionated doses of pions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Pions--the potential for therapeutic gain in locally advanced prostate cancer: dose escalation and toxicity studies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Pion conformal radiation of prostate cancer: results of a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Pion radiation for high grade astrocytoma: results of a randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

RTOG's first quality of life study—RTOG 90-20: A phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Assessment of endpoints for clinical trials for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Comparison of perspectives on prostate cancer: analyses of survey data.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

A method for assessing the quality of life of cancer patients: replication of the factor structure

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

High-dose intravenous pamidronate for metastatic bone pain

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Concurrent validity of the modified Edmonton Symptom Assessment System with the Rotterdam Symptom Checklist and the Brief Pain Inventory

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Patient acceptability and practical implications of pharmacokinetic studies in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Adjuvant psychological therapy for patients with cancer: a prospective randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Assessment of validity and clinical application of an Italian version of the Rotterdam Symptom Checklist

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Longitudinal data analysis (repeated measures) in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Quality-of-life outcomes in men treated for localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Late effects of radiation therapy for prostate carcinoma: the patient's perspective of bladder, bowel and sexual morbidity.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Patient self-assessment of complications and quality of life after conformal neutron and photon irradiation for localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Influence of urological morbidity on quality of life in patients with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Self-assessed sexual function after pelvic irradiation for prostate carcinoma. Comparison with an age-matched control group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

The preservation of potency after external beam irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900341-X

7 January 2021

10.1016/S0959-8049(99)00341-X

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018